NEW YORK (GenomeWeb News) – Marligen Biosciences said today that it has signed an exclusive agreement to distribute Genisphere’s labeling kits for detection of microRNAs on Luminex’s xMAP multiplex platform.
Marligen plans to distribute Genisphere’s kits along with its Vantage product line, which includes kits for purifying, labeling, and detecting microRNA species. Ijamsville, Md.-based Marligen said the complete system offers throughput capabilities of over 100 samples a day and it is compatible with total RNA or enriched RNA including degraded RNA from archived tissues.
The Vantage microRNA panels were designed to profile various microRNAs that are relevant in oncology.
The agreement “will not only advance basic research but should expedite the application of microRNA detection in the diagnosis of cancer,” said Marligen Biosciences Chief Scientific Officer James Lazar.
Financial terms of the agreement were not released.